Skip to content

Tomáš Páleníček

Charles University, National Institute of Mental Health

72 papers in the library · 2,946 citations · publishing 2007-2026

Papers

Sort Most recent Most cited

Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801.

Pharmacology, Biochemistry, and Behavior December 2018 Peter U Hámor, Jana Šírová, Tomáš Páleníček et al.

Chronic methamphetamine (meth) abuse often turns into a compulsive drug-taking disorder accompanied by persistent cognitive deficits and re-occurring psychosis. Possible common neurobiological substrates underlying meth-induced deficits and schizophrenia remain poorly understood. Serotonin 2A (5-HT2A) and metabotropic glutamate 2 (mGlu2) receptors co-regulate psychosis-like behaviors and...

Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats

Frontiers in Neuroscience October 23, 2018 Libor Uttl, Ewa Szczurowska, Kateřina Hájková et al. 24 citations

Synthetic cannabinoid compounds are marketed as ‘legal’ marijuana substitutes, even though little is known about their behavioral effects in relation to their pharmacokinetic profiles. Therefore, in the present study we investigated the behavioral effects of systemic treatment with the two synthetic cannabinoids JWH-073 and JWH-210 and the phytocannabinoid Δ9-THC on locomotor activity and...

Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat

Frontiers in Psychiatry April 24, 2018 Rachel R. Horsley, Eva Lhotková, Kateřina Hájková et al. 20 citations

3,4-methylenedioxypyrovalerone (MDPV) is a potent pyrovalerone cathinone that is substituted for amphetamines by recreational users. We report a comprehensive and detailed description of the effects of subcutaneous MDPV (1-4 mg/kg) on pharmacokinetics, biodistribution and metabolism, acute effects on thermoregulation under isolated and aggregated conditions, locomotion (open field) and sensory...

DOI: 10.3389/fpsyt.2018.00144 (opens in new tab) Pharmacokinetics Pharmacology Thermoregulation Cathinone +6

A role for enhanced functions of sleep in psychedelic therapy?

Adaptive Behavior April 4, 2018 Tom Froese, Iwin Leenen, Tomáš Páleníček 8 citations

After a hiatus of several decades, there has been a resurgence of studies into the therapeutic potential of serotonergic psychedelics. When administered in controlled settings, they have been reported to induce a wide variety of long-lasting positive psychological changes. However, the mechanisms by which psychedelics impart these long-lasting benefits remain poorly understood. Here, we...

Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats

Behavioural Pharmacology March 13, 2018 Rachel R. Horsley, Tomáš Páleníček, Jan Kolin et al. 52 citations

Short-term moderate doses of serotonergic and dissociative hallucinogens can be useful in the treatment of anxiety. Recently, a trend has developed for long-term intermittent 'microdosing' (usually one-tenth of a 'full' active dose), with reports of long-lasting relief from anxiety and related disorders; however, there is no scientific evidence for the efficacy of therapeutic microdosing nor to...

Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats

Frontiers in Psychiatry January 10, 2018 Klára Šíchová, Nikola Pinterová, Monika Židková et al. 28 citations

Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH's and its primary metabolite nor-mephedrone's (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum, brain, lungs, and liver), as well as comparative analysis of their effects on locomotion [open...

DOI: 10.3389/fpsyt.2017.00306 (opens in new tab) Pharmacology Mephedrone Pharmacokinetics Drug

Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers

Psychopharmacology January 5, 2018 Anna Bravermanová, Michaela Viktorinová, Filip Tylš et al. 50 citations

RationaleDisruption of auditory event-related evoked potentials (ERPs) P300 and mismatch negativity (MMN), electrophysiological markers of attentive and pre-attentive cognitive processing, is repeatedly described in psychosis and schizophrenia. Similar findings were observed in a glutamatergic model of psychosis, but the role of serotonergic 5-HT2A receptors in information processing is less...

Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.

European Neuropsychopharmacology December 2017 Tomáš Hložek, Libor Uttl, Lukáš Kadeřábek et al.

Metabolic and behavioural effects of, and interactions between Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are influenced by dose and administration route. Therefore we investigated, in Wistar rats, effects of pulmonary, oral and subcutaneous (sc.) THC, CBD and THC+CBD. Concentrations of THC, its metabolites 11-OH-THC and THC-COOH, and CBD in serum and brain were determined over 24h,...

DOI: 10.1016/j.euroneuro.2017.10.037 (opens in new tab) Full text (opens in new tab) Behaviour Cannabidiol CBD Pharmacokinetics δ9-Tetrahydrocannabinol THC

Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats

Frontiers in Psychiatry November 17, 2017 Kristýna Štefková, Monika Židková, Rachel R. Horsley et al. 82 citations

-methylcathinone) is a synthetic cathinone analog of the recreational drug ecstasy. Although it is marketed to recreational users as relatively safe, fatalities due to hyperthermia, serotonin syndrome, and multi-organ system failure have been reported. Since psychopharmacological data remain scarce, we have focused our research on pharmacokinetics, and on a detailed evaluation of temporal...

DOI: 10.3389/fpsyt.2017.00232 (opens in new tab) Pharmacology Cathinone Mephedrone Pharmacokinetics +3

Synthetic Aminoindanes: A Summary of Existing Knowledge

Frontiers in Psychiatry November 17, 2017 Nikola Pinterová, Rachel R. Horsley, Tomáš Páleníček 37 citations

Objectives: Aminoindanes (“bath salts”, a class of novel psychoactive substances, NPSs) increased rapidly in popularity on the recreational drug market, particularly after mephedrone and other synthetic cathinones were banned in the UK in 2010. Novel aminoindanes continue to emerge, but relatively little is known about their effects and risks. Their history, chemistry, pharmacology, behavioural...

Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study.

Psychopharmacology July 2017 Renáta Androvičová, J Horacek, Jaroslav Tintěra et al.

Self-report studies indicate that cannabis could increase sexual desire in some users. We hypothesized that intoxication increases activation of brain areas responsive to visual erotica, which could be useful in the treatment of hypoactive sexual desire disorder, a condition marked by a lack of sexual desire. The aim of this study is to assess the aphrodisiacal properties of cannabis. We...

Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat

Brain Research Bulletin May 4, 2016 Rachel R. Horsley, Eva Lhotková, Kateřina Hájková et al. 38 citations

Methoxetamine (MXE) is a novel psychoactive compound (NPS) that emerged in 2010 as a substitute for the dissociative anaesthetic ketamine. MXE has a reputation of carrying a lower risk of harm than ketamine, however a number of deaths have been reported. Currently very little is known about the psychopharmacological effects of this compound or its toxicity; therefore we tested, in Wistar rats,...

Sex differences and serotonergic mechanisms in the behavioural effects of psilocin

Behavioural Pharmacology October 13, 2015 Filip Tylš, Tomáš Páleníček, Lukáš Kadeřábek et al. 86 citations

Psilocybin has recently attracted a great deal of attention as a clinical research and therapeutic tool. The aim of this paper is to bridge two major knowledge gaps regarding its behavioural pharmacology – sex differences and the underlying receptor mechanisms. We used psilocin (0.25, 1 and 4 mg/kg), an active metabolite of psilocybin, in two behavioural paradigms – the open-field test and...

The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat

Frontiers in Behavioral Neuroscience May 16, 2014 Lukáš Rambousek, Tomáš Páleníček, Karel Valeš et al. 55 citations

The involvement of the serotonin system in the pathophysiology of schizophrenia has been elucidated by experiments with hallucinogens. Application of a hallucinogen to humans leads to changes in perception, cognition, emotions, and induction of psychotic-like symptoms that resemble symptoms of schizophrenia. In rodent studies, their acute administration affects sensorimotor gating, locomotor...

DOI: 10.3389/fnbeh.2014.00180 (opens in new tab) Hallucinogen Memory consolidation Water maze Cognition +2

Psilocybin – Summary of knowledge and new perspectives

European Neuropsychopharmacology December 17, 2013 Filip Tylš, Tomáš Páleníček, Jiřı́ Horáček 267 citations

Psilocybin, a psychoactive alkaloid contained in hallucinogenic mushrooms, is nowadays given a lot of attention in the scientific community as a research tool for modeling psychosis as well as due to its potential therapeutic effects. However, it is also a very popular and frequently abused natural hallucinogen. This review summarizes all the past and recent knowledge on psilocybin. It briefly...

DOI: 10.1016/j.euroneuro.2013.12.006 (opens in new tab) Psilocybin Hallucinogen Action physics Pharmacology

Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.

Psychopharmacology 2013 Tomáš Páleníček, Michaela Fujáková, Martin Brunovský et al. 51 citations

Behavioral, neurochemical and pharmaco-EEG profiles of a new synthetic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats were examined. Locomotor effects, prepulse inhibition (PPI) of acoustic startle reaction (ASR), dopamine and its metabolite levels in nucleus accumbens (NAc), EEG power spectra and coherence in freely moving rats were analysed. Amphetamine was used as a reference...

DOI: 10.1007/s00213-012-2797-7 (opens in new tab) Full text (opens in new tab) 2c-b Synthetic compound Substance Neurotransmitters +18

Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats.

Pharmacology, Biochemistry, and Behavior March 2011 Tomáš Páleníček, Marie Balíková, Miroslava Rohanová et al.

Despite poisoning with the ecstasy substitute para-methoxymethamphetamine (PMMA) being typically associated with severe hyperthermia and death, behavioral and toxicological data on this drug are missing. Herein we present the behavioral profile of PMMA, its hyperthermic potency and pharmacokinetic profile in rats. The effects of PMMA 5 and 20 mg/kg on locomotion, on prepulse inhibition (PPI) of...

Electroencephalographic Spectral and Coherence Analysis of Ketamine in Rats: Correlation with Behavioral Effects and Pharmacokinetics

Neuropsychobiology 2011 Tomáš Páleníček, Michaela Fujáková, Martin Brunovský et al. 85 citations

AIMS: This study was designed to evaluate the changes in EEG power spectra and EEG coherence in a ketamine model of psychosis in rats. Analyses of behavioral measurements--locomotion and sensorimotor gating--and the pharmacokinetics of ketamine and norketamine were also conducted. METHODS: Ketamine and norketamine levels in rat sera and brains were analyzed by gas chromatography-mass...

DOI: 10.1159/000321803 (opens in new tab) Ketamine Electroencephalography Prepulse inhibition Pharmacokinetics +4

Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition.

Progress in Neuro-Psychopharmacology and Biological Psychiatry May 30, 2010 Tomáš Páleníček, Zdenek Hlinák, Vĕra Bubeníková‐valešová et al.

The aim of this study was to describe sex differences in the behavioural effects of N,N-diethyllysergamide (LSD) (locomotor activity and other behavioural repertoire in the open field) and its effects on sensorimotor gating in rats (prepulse inhibition (PPI) of the acoustic startle reaction). Three groups of animals were analysed: males, oestral and pro-oestral phase females (EP females), and...

Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect

Psychological Medicine December 9, 2009 Jiřı́ Horáček, Martin Brunovský, Tomáš Novák et al. 42 citations

BACKGROUND: Theta cordance is a novel quantitative electroencephalography (QEEG) measure that correlates with cerebral perfusion. A series of clinical studies has demonstrated that the prefrontal theta cordance value decreases after 1 week of treatment in responders to antidepressants and that this effect precedes clinical improvement. Ketamine, a non-competitive antagonist of...

DOI: 10.1017/s0033291709991619 (opens in new tab) Ketamine Nmda receptor Antidepressant Placebo +6

Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration.

Toxicology Letters April 21, 2008 Miroslava Rohanová, Tomáš Páleníček, Marie Balíková 33 citations

The psychedelic compound 4-bromo-2,5-dimethoxyphenethylamine (2C-B) has appeared as an agent in drug abuse or overdose cases in humans. The human pharmacokinetics of this drug is unknown and only partial information is available on its metabolites. Our experimental study was focused on the disposition and kinetic profile of 2C-B in rats after subcutaneous administration using a GC-MS validated...

DOI: 10.1016/j.toxlet.2008.01.017 (opens in new tab) Full text (opens in new tab) 2c-b Psychedelic compound Original compound Pharmacokinetics +14

Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose

Psychopharmacology October 6, 2007 Tomáš Páleníček, Marie Balı́ková, Vĕra Bubeníková‐valešová et al. 61 citations

RationaleMescaline is a nonselective serotonin receptor agonist. It has relatively delayed onset of action and prolonged duration. Mescaline attenuates various behavioral parameters in rats; however, no information is available about its pharmacokinetics in rats and its relation to the behavioral changes produced by the drug.ObjectivesThe present study evaluates the spontaneous locomotor...

DOI: 10.1007/s00213-007-0926-5 (opens in new tab) Mescaline Prepulse inhibition Pharmacology Pharmacokinetics +3